{"id":"W4256065302","doi":"10.14694/edbook_am.2013.33.e20","title":"Treatment Algorithms for Hormone Receptor-Positive Advanced Breast Cancer: Applying the Results from Recent Clinical Trials into Daily Practice—Insights, Limitations, and Moving Forward","year":2013,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Exemestane; Fulvestrant; Breast cancer; Medicine; Tamoxifen; Oncology; Everolimus; Aromatase inhibitor; Estrogen receptor; Internal medicine; Clinical trial; Metastatic breast cancer; Aromatase; Letrozole; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.1789983,0.001837871,0.006125283,0.005362912,0.001141615,0.01427668,0.005183729,0.003233001,0.003265301],"category_scores_gemma":[0.3024538,0.001234298,0.003295535,0.0050222,0.003379968,0.01204374,0.005037383,0.008435351,0.001143735],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.006164453,"about_ca_system_score_gemma":0.01169744,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002532344,"about_ca_topic_score_gemma":0.004003828,"domain_scores_codex":[0.8463372,0.1182676,0.01784723,0.004922645,0.01171248,0.0009128166],"domain_scores_gemma":[0.6650921,0.2465839,0.02989519,0.0122968,0.04104489,0.00508715],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001549401,0.0002311718,0.01325904,0.01673776,0.003785371,0.00006495152,0.0008036732,0.006159835,0.0004568505,0.02511302,0.04352829,0.8883107],"study_design_scores_gemma":[0.005883215,0.00543583,0.04432938,0.1012325,0.01213345,0.001000677,0.003269394,0.09860333,0.002302896,0.3072292,0.4176733,0.0009068599],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01770835,0.5404882,0.1317951,0.2846434,0.006619212,0.00311422,0.001564734,0.00107428,0.01299256],"genre_scores_gemma":[0.3047491,0.1814132,0.4385283,0.05686415,0.008318439,0.00523018,0.00249817,0.0007500122,0.001648521],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.1789983,"threshold_uncertainty_score":0.9466446,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.146921058944241,"score_gpt":0.505966747079464,"score_spread":0.359045688135223,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}